Updated Feb. 18, 2013 at 6:32 a.m.
GSK's R&D facility in RTP. (GSK photo)
Pharmaceutical stocks of GlaxoSmithKline among others, which have soared in the past year to valuations not seen since 2001, are poised to extend their rally as investors grow more confident the industry has weathered a decade-long shortage of new drugs....
For GSK, other drug giants, pipelines rebound - and so do stocks
Post a comment
Print this blog postE-mail blog post
Share
GSK's R&D facility in RTP. (GSK photo)
Pharmaceutical stocks of GlaxoSmithKline among others, which have soared in the past year to valuations not seen since 2001, are poised to extend their rally as investors grow more confident the industry has weathered a decade-long shortage of new drugs....
WRAL Tech Wire any time: Twitter, Facebook
Copyright 2013 WRAL Tech Wire. All rights reserved.Please log in or register to view WRALTechWire Insider content
To access this premium content and other benefits, become a WRAL TechWire Insider. Daily, monthly, and annual memberships available.
Please Log In to add a comment.
Best of TechWire Insider
OUR INSIDERS
WRAL TechWire Editor
The Skinny
At last! Sprint 4G service formally launches in Triangle- Big Blue's layoff total climbs in RTP; North America total surges past 2,800
- Big Blue layoff count nears 2,800 in North America alone
- NC's high-tech job picture improves in May, but ...
- IBM layoff count hits nearly 2,300 across 31 work groups
- NC IDEA: Startup deal flow 'better than it has ever been'
- IBM's job cuts are global, nearing 4,000; most are in U.S.
- CEO fears for future of NC Biofuels Center due to budget cuts
- Workers 50+ take biggest hit among 14% reduction in IBM marketing group
- 'Anxiety and disruption:' IBM's form letter for layoffs